logo
Renewed calls to make major driver's licence change for older Aussies: 'We have to'

Renewed calls to make major driver's licence change for older Aussies: 'We have to'

Yahoo13 hours ago
The discussion of whether older Australians should be subject to additional driver's licence requirements has been reignited following a fatal car accident involving a 91-year-old driver.
Authorities in Victoria are looking to review the road rules after a two-year-old boy was hospitalised and two adults, thought to be his grandparents, died after they were hit while walking on a suburban street in Melbourne last week.
The elderly woman behind the wheel at the tragedy in the Melbourne suburb of Wantirna South last Thursday was "terribly shaken", police said. She was taken to hospital with minor injuries and has yet to be interviewed by police.
The morning after the incident, Victoria's Acting Premier Ben Carroll renewed the discussion on driving regulations for the elderly and confirmed he would work with the road safety minister on the matter.
Road safety advocates across the country have since weighed in on the debate, with Russell White, founder of the Australian Road Safety Foundation, arguing the latest incident should be the catalyst for standardised change across the country.
"Sadly, it's taken someone to have a serious incident and for lives to be lost for us to have discussions like this," he told Yahoo News.
"We have to try and look at how we become more proactive in this space and take some probably hard decisions to alter what people's view is on driving."
Victoria does not have age-based driving safety requirements, although drivers aged 75 and older must renew their licence every three years, which can involve various tests.
In NSW, Queensland, the ACT, Tasmania and the Northern Territory, drivers older than 75 are required to have a health check, while older drivers in South Australia must complete self-assessments.
In Western Australia, an annual medical assessment is required to renew a driver's licence after turning 80.
White believes all drivers need more rigorous training over the years after they acquire their licence.
"In an ideal world, I would like to see some form of additional coaching that happens," he said. It could come with a practical driving evaluation once a decade, he suggested. While he believes that it may be unpopular to implement such a framework, saving lives is the ultimate priority.
"We've got to look at standardising the framework for older drivers, including lifelong learning as far as coaching is concerned," he said.
Startling statistics released in the past year reveal elderly drivers are disproportionately represented in road crash statistics.
Older drivers aged 85 and up are disproportionately affected by fatal crashes, according to data by Road Safety Education Limited (RSE) earlier this year, while insurance company AAMI singled out senior Australians as risky drivers in their Decade of Driving report.
Following the incident, Dr Anita Muñoz, Victorian chair of the Royal Australian College of General Practitioners, argued that age is not an innate barrier to safe driving and people of all ages must recognise their responsibility when it comes to being a safe driver.
"Fitness to drive and safety on the road is, however, something we should all be proactive about — for ourselves, with our family members, and as GPs, with our patients," she said.
"There's an association between our health and our social connectedness and mobility, so it's valuable for older people to continue to drive, but only for as long as it is safe.
"Proactive discussions about safety on the road are part of what we as GPs discuss with older patients, but it's something you should think about too, for yourself and others in your life."
Ben Rogers, CEO of Council on the Ageing (COTA) Victoria, which represents the interests of older Australians, cautioned against licensing requirements, arguing that Victoria leads the country in how it approaches the issue by focusing on "ability rather than age".
"We don't want to see any sort of legislation change in Victoria, but we are happy to have the conversation about mandatory testing for all drivers," he told Yahoo. "It's incumbent on all of us on the roads to make sure that we are driving safely.
"Driving is a privilege, no matter whether you're 45 or 75, if you are not fit to drive you shouldn't be on the roads."
He believes family, friends, and medical practitioners should be supporting conversations with drivers about their fitness to drive across all age groups and ensuring that subsidised additional training is available for those who wish to partake in it.
Investigations into the exact circumstances surrounding the collision at Wantirna South remain ongoing, Victoria Police confirmed.
— With AAP
Do you have a story tip? Email: newsroomau@yahoonews.com.
You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New weekly injection for Parkinson's could replace daily pill for millions, study suggests
New weekly injection for Parkinson's could replace daily pill for millions, study suggests

Fox News

time3 hours ago

  • Fox News

New weekly injection for Parkinson's could replace daily pill for millions, study suggests

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for daily pills. Scientists from the University of South Australia (UniSA) developed a long-acting injectable formulation that provides two key Parkinson's medications for an entire week. There is currently no cure for Parkinson's, which is the second-most common neurological disorder, affecting more than one million Americans, according to the Parkinson's Foundation. To manage symptoms like tremors, rigidity and slow movement, patients typically take daily oral medications, such as levodopa and carbidopa, according to the university's press release. This method can be especially difficult for individuals who have trouble swallowing or are otherwise unable to take the pills consistently, leading to irregular medication levels, increased side effects and reduced effectiveness. Levodopa is the "gold-standard therapy for Parkinson's," according to lead researcher Professor Sanjay Garg at UniSA, but its short lifespan means it must be taken several times a day. The researchers tested an injectable gel implant that combines an FDA-approved biodegradable substance with a pH-sensitive substance to achieve a controlled and sustained drug release. The gel is injected through a single shot under the skin or into the muscle tissue, which means there's no need for a surgical implant and discomfort is minimal, they noted. The team found that the gel gradually released the key Parkinson's medications (90% of the levodopa drug and 81% of the carbidopa) over the course of one week. The findings were published in the journal Drug Delivery and Translational Research. "Reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson's therapy," Garg said in the release. "We're not just improving how the drug is delivered; we're improving patients' lives." Extensive lab tests confirmed the system's effectiveness and safety. "We're not just improving how the drug is delivered; we're improving patients' lives." The implant degraded by over 80% within a week and showed no significant toxicity in cell viability tests. "The implications of this research are profound," Garg added. Deepa Nakmode, a PhD student at the University of South Australia, noted that this method is designed to release both levodopa and carbidopa steadily over one week, maintaining consistent plasma levels and reducing the risks associated with fluctuating drug concentrations. "After years of focused research, it's incredibly rewarding to see our innovation in long-acting injectables for Parkinson's disease reach this stage," he said in the release. The team's invention has now been filed for an Australian patent, Nakmode added. The technology could also be adapted for other chronic conditions, such as cancer, diabetes, neurodegenerative disorders, chronic pain and infections that require long-term drug delivery, according to Garg. The system can be tuned to release drugs over a period ranging from a few days to several weeks, depending on therapeutic needs. For more Health articles, visit Scientists hope to start clinical trials in the near future and are exploring opportunities to make the gel commercially available.

New Core Outcomes May Transform Stillbirth Care
New Core Outcomes May Transform Stillbirth Care

Medscape

time6 hours ago

  • Medscape

New Core Outcomes May Transform Stillbirth Care

TOPLINE: A new core outcome set for stillbirth care developed with the input from international stakeholders can be used in future trials and systematic reviews to reduce outcome-reporting bias, facilitate comparisons of interventions in meta-analyses, and ultimately reduce research wastage. METHODOLOGY: Researchers conducted an international consensus study using data from the modified Delphi method and consensus meetings to develop a core outcome set to guide future stillbirth care research. The core outcome set was developed following the methodological consensus standards outlined by the Core Outcome Measures in Effectiveness Trials initiative standards and supported by the relevant published literature. Researchers invited 542 stakeholders, including 381 parents or family members who had experienced stillbirth and 192 healthcare professionals or researchers (31 of whom identified as both a parent and a professional), from 29 countries across Africa, Australia, Europe, North America, South America, and Asia. Participants completed two rounds of Delphi surveys using Research Electronic Data Capture, followed by four consensus meetings to determine the final core outcome set. TAKEAWAY: Core outcomes for all stillbirth care studies were life-threatening complications, maternal death, parents' experience of respectful and supportive care, grief, mental health and emotional well-being, isolation, stigma, impact on work, and impact on family relationships. For studies investigating the cause of stillbirth, researchers identified two additional core outcomes: identification of the cause of death and parents' understanding of that cause. Studies assessing subsequent pregnancy care should measure outcomes such as antenatal complications for the mother and baby, baby survival, neonatal outcomes, and attachment to the baby. Studies focusing on stillbirth associated with a multiple pregnancy should consider outcomes such as survival of other babies, preterm birth, pregnancy complications for the baby, and neonatal outcomes. IN PRACTICE: "The development of a minimum agreed set of outcomes represents a significant milestone to address inconsistent outcome collection and reporting in studies of care after stillbirth," the authors wrote. SOURCE: This study was led by Danya Bakhbakhi, Translational Health Sciences, University of Bristol, Bristol, England. It was published online on July 07, 2025, in BJOG: An International Journal of Obstetrics & Gynaecology. LIMITATIONS: Overall, 69.8% of participating parents had university or college education, which is higher than the population average, potentially affecting the generalisability of the core outcome set. The majority of stakeholders were from high-income countries. This study did not include stakeholders who did not speak English. DISCLOSURES: This study received support from the National Institute for Health and Care Research through a doctoral fellowship. Two authors reported receiving grant funding for stillbirth research. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store